"Pseudomyxoma Peritonei" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A condition characterized by poorly-circumscribed gelatinous masses filled with malignant mucin-secreting cells. Forty-five percent of pseudomyxomas arise from the ovary, usually in a mucinous cystadenocarcinoma (CYSTADENOCARCINOMA, MUCINOUS), which has prognostic significance. Pseudomyxoma peritonei must be differentiated from mucinous spillage into the peritoneum by a benign mucocele of the appendix. (Segen, Dictionary of Modern Medicine, 1992)
| Descriptor ID |
D011553
|
| MeSH Number(s) |
C04.557.470.590.782
|
| Concept/Terms |
Pseudomyxoma Peritonei- Pseudomyxoma Peritonei
- Gelatinous Ascites
- Syndrome of Pseudomyxoma Peritonei
- Pseudomyxoma Peritonei Syndrome
- Pseudomyxoma Peritonei Syndromes
- Ascites, Gelatinous
|
Below are MeSH descriptors whose meaning is more general than "Pseudomyxoma Peritonei".
Below are MeSH descriptors whose meaning is more specific than "Pseudomyxoma Peritonei".
This graph shows the total number of publications written about "Pseudomyxoma Peritonei" by people in this website by year, and whether "Pseudomyxoma Peritonei" was a major or minor topic of these publications.
![]()
To see the data from this visualization as text,
click here.
Below are the most recent publications written about "Pseudomyxoma Peritonei" by people in Profiles.
-
Mercier F, Jeremie G, Alyami M, Delphine V, Vahan K, Pascal R, Sylvie I, Guillaume P, Olivier G. Long-term results of laparoscopic cytoreductive surgery and HIPEC for the curative treatment of low-grade pseudomyxoma peritonei and multicystic mesothelioma. Surg Endosc. 2020 11; 34(11):4916-4923.
-
Galan A, Rousset P, Mercier F, K?p?n?kian V, Valette PJ, Glehen O, Passot G. Overall survival of pseudomyxoma peritonei and peritoneal mesothelioma patients after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy can be predicted by computed tomography quantified sarcopenia. Eur J Surg Oncol. 2018 11; 44(11):1818-1823.